AstraZeneca PLC (UK) Today
| 0A4J Stock | 63.80 0.81 1.29% |
Performance0 of 100
| Odds Of DistressLess than 34
|
AstraZeneca PLC is selling for under 63.80 as of the 23rd of November 2024; that is 1.29% increase since the beginning of the trading day. The stock's lowest day price was 63.57. AstraZeneca PLC has about a 34 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for AstraZeneca PLC ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of October 2024 and ending today, the 23rd of November 2024. Click here to learn more.
Moving together with AstraZeneca Stock
Moving against AstraZeneca Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AstraZeneca Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
AstraZeneca PLC ADR (0A4J) is traded on London Exchange in UK and employs 89,900 people. AstraZeneca PLC is listed under Environmental & Facilities Services category by Fama And French industry classification. The company operates under Commercial Services & Supplies sector and is part of Industrials industry.
AstraZeneca PLC generates positive cash flow from operations, but has no cash available
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership AllocationAlmost 83.25 percent of AstraZeneca PLC outstanding shares are held by general public with 16.75 % by other corporate entities.
Check AstraZeneca Ownership Details
AstraZeneca PLC ADR Risk Profiles
Although AstraZeneca PLC's alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.0 | |||
| Standard Deviation | 1.53 | |||
| Variance | 2.35 | |||
| Risk Adjusted Performance | (0.24) |
AstraZeneca Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
AstraZeneca PLC Corporate Management
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pam Cheng | EVP Board | Profile | |
| Katarina Ageborg | Chief Sustainability | Profile | |
| Jeffrey Pott | Chief CHRO | Profile | |
| Ruud Dobber | Executive Unit | Profile |
Additional Tools for AstraZeneca Stock Analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.